Pruritus Therapeutics Market Analysis ,Future Scope And Forecast To 2025Posted by Neha Bora on April 25th, 2023 San Francisco, 25 April 2023: The Report Pruritus Therapeutics Market By Product (Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Pipeline, Unmet Needs), By Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria) Analysis And Segment Forecasts To 2025 The global pruritus therapeutics market is expected to reach USD 16.38 Billion by 2025, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis, and urticaria is expected to drive market growth during the forecast period. The introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period. Corticosteroids were the leading product segment in 2013 owing to high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing inflammation and itching. Topical applications of corticosteroids have been found to be extremely effective in the treatment and maintenance therapies pertaining to pruritus. Access Research Report of Pruritus Therapeutics Market @ https://www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market Further key findings from the study suggest:
Access Press Release of Pruritus Therapeutics Market @ https://www.grandviewresearch.com/press-release/global-pruritus-therapeutics-market Like it? Share it!More by this author |